Hepatitis C virus (HCV) is a major cause of chronic liver disease. It has been estimated that the prevalence of HCV is ∼3% worldwide and is as high as 22% in some countries. Approximately 5%-20% of patients with chronic hepatitis C will eventually progress to cirrhosis, hepatocellular carcinoma, and liver failure [1, 2] . The primary site of HCV infection and replication is the liver, where most of the immunopathological events associated with HCV infection occur.
Polychromatic flow-cytometri assays were used to analyze paired intrahepatic and peripheral lymphocyte samples from 37 patients with chronic hepatitis C. Compared with peripheral cells, intrahepatic T cells were selectively enriched with CD45RO + memory T cells but had a lower percentage of CD4 + T cells expressing the differentiation markers CD27 and CD28. The percentage of intrahepatic CD45RO + and CD28 + T cells correlated with the degree of liver inflammation which suggests that memory T cells at relatively early stages of differentiation are directly involved in liver inflammation Despite their memory phenotype, intrahepatic T cells were defective in proliferation capability, produced less interferon-g in response to stimulation by T cell receptor, and contained less perforin but expressed higher levels of Fas and Fas ligand, compared with their counterparts in peripheral blood. The distinct characteristics of intrahepatic T cells suggest that they play an important role in the immunopathogenesis of chronic hepatitis C.
Hepatitis C virus (HCV) is a major cause of chronic liver disease. It has been estimated that the prevalence of HCV is ∼3% worldwide and is as high as 22% in some countries. Approximately 5%-20% of patients with chronic hepatitis C will eventually progress to cirrhosis, hepatocellular carcinoma, and liver failure [1, 2] . The primary site of HCV infection and replication is the liver, where most of the immunopathological events associated with HCV infection occur.
In the majority of infected individuals, HCV persists and leads to chronic hepatitis C. The mechanisms of HCV persistence and hepatocyte injury are poorly understood. It is thought that T cell-mediated immunity plays an important role both in eradicating HCV and in causing liver injury [3] . However, little is known about the characteristics of immune T cells in the HCV-infected liver. The mechanisms of the traffickin of peripheral lymphocytes into the liver, the developmental and differentiation status of intrahepatic lymphocyte (IHL) subsets, and, most important, the functional status of these cells during chronic HCV infection are largely unknown. This is because of the difficultie in obtaining enough liver tissue for the phenotypic and functional analysis of IHLs. We previously reported a comprehensive analysis of multiple chemokine receptors on IHLs and their relationship to liver inflammatio in chronic hepatitis C. In that study, paired percutaneous liver-biopsy and peripheral-blood specimens from 23 patients with chronic HCV infection were used to identify the correlation between the expression frequencies of multiple chemokine receptors on IHL subsets and hepatic inflammatio [4] . In the present study, we have conducted additional phenotypic analyses of intrahepatic and peripheral T cells for the T cell differentiation markers. We have also extended our characterization of IHLs by performing functional analyses for ex vivo cytokine production and in vitro proliferation with paired IHLs and peripheral blood mononuclear cells (PBMCs) from additional study patients.
PATIENTS, MATERIALS, AND METHODS

Patients and specimens.
Thirty-seven patients with chronic hepatitis C who were undergoing diagnostic liver biopsy (table  1) provided consent and enrolled in the study. Biopsy specimens were processed and scored by a pathologist for necroinflammatio activity and fib osis using a modificatio of the histologic activity index proposed by Knodell et al. [5] and Batts and Ludwig [6] on a scale of 0-4. Excess tissues from the liver-biopsy samples were used to prepare IHLs. A venous blood sample was collected from each patient on the day of biopsy.
The study protocol was approved by the institutional review boards at Stanford University and the University of California, San Francisco.
Preparation of IHLs and PBMCs.
IHLs and PBMCs were isolated as described elsewhere [7] . In brief, liver-biopsy samples weighing 40-80 mg were washed with 10 mL of RPMI 1640 medium with 10% fetal calf serum (FCS; complete RPMI medium) and mechanically disrupted with the small pestle of a Dounce tissue grinder fille with 5 mL of fresh complete Flow-cytometric analysis of phenotypic markers on CD4 + and CD8 + T cells in the liver (intrahepatic lymphocytes [IHLs]) and peripheral blood mononuclear cells (PBMCs). IHL and PBMC samples were stained with monoclonal antibodies for CD4, CD8, CD45RO, CD27, and CD28. The position of markers for each antibody was set by using cells stained with appropriate isotype control antibodies. FSC, forward scattering; SSC, side scattering.
RPMI medium, to release IHLs. The cell suspension was centrifuged at 300 g for 10 min to pellet the cells. Cells were resuspended in complete RPMI medium and counted. PBMCs were isolated from venous blood by standard Ficoll-Paque (Amersham) gradient centrifugation.
Cell staining and flow-cytometri analysis. Aliquots of IHLs ( ) or PBMCs ( ) were resuspended in 30 6 6 0.5 ϫ 10 1 ϫ 10 mL of FACS buffer (0.5% bovine serum albumin and 0.05% NaN 3 in PBS) for all of the staining procedures. For staining of CD28 or Fas ligand (FasL, CD178), the cells were firs stained with biotinylated mouse anti-human CD28 monoclonal antibody (MAb; Vector Laboratories) or biotinylated anti-FasL (BD Biosciences), respectively, followed by staining with streptavidin-peridinin-chlorophyll-protein complex-Cy5.5 (BD Biosciences). For staining of all other cell-surface markers, the cells were firs stained for CD28 or FasL (if applicable), followed by staining with combinations of the following fluo escenceconjugated MAbs (all from R&D Systems unless otherwise specified) CD4-phycoerythrin (PE)-Cy7, CD8-allophycocyanin (APC)-Cy7, CD45RO-APC (Caltag), Fas-APC, and CD27fluo escein isothiocyanate (FITC). For staining of intracellular interferon (IFN)-g and perforin, cells were firs stained for cell-surface markers. After fixatio and permeabilization with FACS Lysing Solution and FACS Permeabilizing Solution (BD Biosciences), the cells were stained with IFN-g-PE and perforin-FITC (BD Biosciences). All staining steps were performed for 30 min at room temperature, followed by washing with FACS buffer. The stained cells were fixe with 1% paraformaldehyde and analyzed on an LSR II flo cytometer (BD Biosciences), using FACSDiVa Software (version 2.2.1; BD Biosciences).
Carboxyfluo escein diacetate succinimidyl ester (CFSE) labeling. Freshly prepared IHLs (1 ϫ 10 6 ) or PBMCs (2 ϫ 10 6 ) were washed twice with PBS and resuspended in 1 mL of PBS. CFSE (Molecular Probes) was added to the fina concentration of 0.5 mmol/L, and the cells were incubated for 10 min at room temperature, before the addition of an equal volume of FCS and incubation for an additional 1 min at room temperature to stop the reaction. The labeled cells were washed twice and resuspended with complete RPMI medium.
IFN-g flo cytometry.
Freshly prepared IHLs (0.5 ϫ 10 6 -1 ϫ 10 6 ) or PBMCs ( ) were resuspended in 0.5 mL of 6 2 ϫ 10 complete RPMI medium and incubated for 5 h at 37ЊC in 5% CO 2 in the presence of Brefeldin A (10 mg/mL; Sigma-Aldrich), with or without the addition of staphylococcal enterotoxin B (SEB; Sigma-Aldrich) at a fina concentration of 10 mg/mL. For the IHL/PBMC mixed-culture experiment, either IHLs or PBMCs were firs labeled with CFSE and then mixed with each other for the SEB stimulation. After stimulation, cells were stained for cell-surface markers, fixe and permeabilized, then stained for intracellular IFN-g and perforin.
In vitro proliferation assay. CFSE-labeled IHLs ( ) 6 1 ϫ 10 or PBMCs ( ) were resuspended in RPMI 1640 medium 6 2 ϫ 10 supplemented with 20% of FCS, with or without the addition of recombinant interleukin (rIL)-2 (40 U/mL; Chiron) and anti-CD3 MAb (0.08 mg/mL; Immunotech). The cells were incubated at 37ЊC in 5% CO 2 . For the IHL/PBMC mixed-culture experiment, CFSE-labeled IHLs or PBMCs from the same donor were mixed at a 1:1 ratio for the stimulation. On day 3, one-half of the medium in each well was replaced with fresh medium, with and without rIL-2, respectively. The cells were stained at day 7 for cell-surface markers and analyzed using flo cytometry.
Figure 2.
Frequencies of intrahepatic and peripheral T cell subsets expressing CD45RO, CD27, and CD28 according to grade of liver inflammation. Twenty-three patients (patients 1-23 in table 1) were included. Regression models were fitted with generalized estimating equations. Liver (L), blood (B), and L vs. B P values are the attained significance levels for the linear effect of inflammation score on the frequencies of each marker expression on intrahepatic lymphocyte subsets, on peripheral lymphocyte subsets, and for the average difference between intrahepatic and peripheral lymphocyte subsets at inflammation grade 2, respectively. Underlined P values (!.05) are considered to be statistically significant.
Statistical analysis.
Generalized estimating equations (GEEs) [8] were used to test the response of marker expression frequencies to (1) different inflammatio grades among patients and (2) different sites (intrahepatic vs. peripheral) within patients. Average frequencies of IFN-g production and the expression of perforin, Fas, and FasL were compared between IHLs and PBMCs using the paired Student's t tests. Hypothesis tests were considered to be statistically significan for attained significanc levels of . P ! .05
RESULTS
Expression of Differentiation Markers on CD4 + and CD8 + T Cells and Their Relationship to Liver Inflammation
We used polychromatic flow-cytometri analysis to characterize the surface phenotypes of CD4 + and CD8 + T cells in IHLs and PBMCs from patients with chronic HCV infection. Figure 1 shows an analysis of the T cell differentiation markers CD45RO, CD27, and CD28 on CD4 + and CD8 + T cells in paired IHL and PBMC samples from a representative patient. To compare the relative abundance of T cells expressing these markers and to explore their relationship with liver inflammation we use GEEs to fi the frequency of each marker to a multiple-regression model (figu e 2). The results are summarized below.
Comparison between intrahepatic and peripheral T cells.
As indicated by the liver versus blood P values (figu e 2), average expression frequencies of CD45RO were significantl higher ( ) for both CD4 + and CD8 + T cells in IHLs than P ! .001 in PBMCs. By contrast, the average expression frequencies of CD27 were significantl higher ( ) for both CD4 + and P ! .01 CD8 + T cells in PBMCs than in IHLs. The slope of expression frequency over inflammatio grade differed significantl (P ! ) between IHLs and PBMCs for CD28 on both CD4 + and .05 CD8 + T cells. Therefore, the frequency of CD28 expression tended to be lower in the liver than in the peripheral blood in patients with milder inflammatio but higher in the liver than in the peripheral blood in patients with more severe inflammation
Relationship to hepatic inflammatio grade. The average expression frequencies of CD45RO and CD28 on intrahepatic CD4 + and CD8 + T cells tended to increase with the degree of inflammatio as assessed by the inflammatio grade. This increase was significan for CD45RO on CD4 + T cells ( ) P ! .001 and on CD8 + T cells ( ) and for CD28 on CD4 + T cells P p .013 ( ) but not for CD28 on CD8 + T cells ( ). Av-P ! .001 P p .066 erage expression frequencies of CD45RO on peripheral CD4 + T cells also tended to increase with inflammatio in the liver, Table 2 
. Phenotypes of CD4 + and CD8 + T cells in the liver and peripheral blood at inflammation grade 2.
Phenotype although the increase was not significan ( ). By con-P p .099 trast, the average expression frequency of CD27 on peripheral CD4 + T cells decreased significantl with liver inflammatio ( ) . P p .029
Relationship to serum alanine aminotransferase (ALT) level. An analysis was conducted to examine the relationship between the expression levels on intrahepatic CD45RO, CD27, and CD28 T cells and the serum ALT level of each individual patient.
There was no significan correlation between the expression of these markers on either CD4 + or CD8 + T cells and ALT level (data not shown).
Coexpression of CD45RO, CD27, and CD28 on T cells. We
further classifie CD4 + and CD8 + T cells into 8 phenotype subsets on the basis of the expression pattern of CD45RO, CD27, and CD28 (table 2) . Using GEEs, we estimated the mean percentages of each phenotype at inflammatio grade 2 and compared them between intrahepatic and peripheral sites. In both IHLs and PBMCs, cells expressing all 3 of these markers (CD45RO + CD27 + CD28 + ) were the most abundant subset:
145% of all CD4 + T cells and intrahepatic CD8 + T cells and ∼29% of peripheral CD8 + T cells. The most substantial difference (13-fold) between levels in intrahepatic and peripheral T cells was in the percentage of the CD45RO Ϫ CD27 + CD28 + subset, which was 28.7%-35.1% in PBMCs but only 8.3%-9.3% in IHLs. The mean percentages of all the other subsets were higher in IHLs than in PBMCs, except for the CD45RO Ϫ CD27 + CD28 Ϫ and CD45RO Ϫ CD27 Ϫ CD28 Ϫ CD8 + T cell subsets, which were higher in PBMCs than in IHLs; however, the difference was statistically significan only for the CD45RO Ϫ CD27 + CD28 Ϫ subset.
Production of IFN-g by Intrahepatic and Peripheral T Cells
We compared the ability of intrahepatic and peripheral T cells to produce IFN-g after ex vivo stimulation with the superantigen SEB. In paired IHL and PBMC samples from 6 randomly selected patients, the average frequency of IFN-g-producing CD4 + and CD8 + T cells in IHLs was significantl lower than that in PBMCs ( ) (figu e 3A). To exclude the possibility P ! .006 that this difference was caused by liver-derived extracellular suppressive factor(s) in the IHL preparation, we performed a mixed IHL/PBMC experiment. Either IHLs or PBMCs were labeled with CFSE before mixing. In both mixed cultures with either IHLs or PBMCs labeled with CFSE, the levels of IFN-g production in CD4 + and CD8 + T cell subsets from the liver were lower than those from the peripheral blood (figu e 3B), which indicates that the limited IFN-g production of intrahepatic T cells is an intrinsic characteristic of these T cells per se.
Expression of Perforin, FasL, and Fas by Intrahepatic and Peripheral T Cells
FasL/Fas and perforin pathways are the 2 major mechanisms of T cell-mediated cytotoxicity [9, 10] . To compare the cytotoxic activity of intrahepatic and peripheral T cells in patients with chronic HCV infection, we examined the levels of intracellular perforin and cell-surface FasL in the CD4 + and CD8 + T cell subsets from paired IHL and PBMC samples (figu e 4). Intrahepatic CD8 + T cells expressed significantl lower levels of perforin than peripheral CD8 + T cells ( ). By con-P p .004 trast, the levels of FasL on intrahepatic CD4 + and CD8 + T cells were significantl higher than those on the peripheral T cells ( for both CD4 + and CD8 + T cells). P ! .001
In addition, we examined the expression levels of Fas, the re-ceptor for FasL, on intrahepatic CD4 + and CD8 + T cells. Intrahepatic CD4 + and CD8 + T cells expressed significantl higher levels of Fas than peripheral T cells ( for CD4 + T cells P p .002 and for CD8 + T cells) (figu e 4). P p .016
Proliferation Capability of Intrahepatic and Peripheral T Cells
We assessed the proliferation capability of CD4 + and CD8 + T cells in the liver and peripheral blood from patients with chronic HCV infection. Paired IHL and PBMC samples were labeled with CFSE and incubated with or without anti-CD3 and rIL-2 for 7 days. As shown in figu e 5, in anti-CD3-and rIL-2-stimulated PBMCs, the vast majority of CD4 + and CD8 + T cells had proliferated on day 7 after stimulation, as indicated by the diluted CFSE signal intensity. By contrast, in anti-CD3and IL-2-stimulated IHLs, there was no proliferation in the vast majority of cells on day 7. Both proliferated and nonproliferated T cells were detected in the mixed IHL/PBMC sample (figu e 5), which indicates that the absence of T cell proliferation in IHLs was due to the intrinsic proliferation defect of intrahepatic, compared with the peripheral, T cells, rather than to a suppressive effect of liver-derived factors present in the IHL preparation.
DISCUSSION
The primary site of both HCV replication and the inflammato y response to HCV is the liver. The infiltratio of lymphocytes increases with disease progression, which suggests that these cells play a role in the pathogenesis of chronic hepatitis C. In our previous report [4] , we showed that CD8 + and CD4 + T cells are the most abundant lymphocyte subsets in the livers of patients with chronic hepatitis C. We also showed that, in patients chronically infected with HCV, the expression of several chemokine homing receptors and activation markers on intrahepatic CD4 + and CD8 + T cells, as well as other lymphocyte subsets, tended to increase with the severity of liver inflam mation. In the present study, we demonstrated that CD4 + and CD8 + T cells with the phenotypes CD45RO + and CD27 Ϫ , as well as CD4 + T cells with the phenotype CD28 Ϫ , are all enriched in the liver, compared with the peripheral blood. More important, with the increasing severity of liver inflammation the percentage of intrahepatic CD45RO + CD4 + and CD8 + T cells increased significantly the percentage of intrahepatic CD28 + T cells also increased, and the increase was significan for CD4 + T cells. These results suggest an association between the frequency of intrahepatic memory T cells at an early differentiation stage (CD28 + ) and the severity of liver inflammatio [11] [12] [13] . No significan correlation was detected between frequencies of these markers and serum ALT levels, which is consistent with the poor correlation between serum ALT level and liver inflammatio grade in chronic hepatitis C [14] . Of note, our data suggest different patterns of association between CD45RO, CD27, and CD28 and liver inflammation even though all 3 of these markers are thought to be related to T cell differentiation. This needs to be further studied in the future by examining the phenotypes of HCV-specifi T cells in the liver.
To directly assess the functional status of intrahepatic CD4 + and CD8 + T cells, compared with that of their counterparts in the peripheral blood, we performed single cell-based IFN-g cytokine flow-cytometri analysis. IFN-g has important immune regulatory function [15, 16] and is involved in the noncytolytic control of hepatic viral infections mediated by virusspecifi T cells [17] [18] [19] [20] . A previous study using a mouse model suggested that virus-specifi CD8 + T cells in the liver and the spleen had comparable ability to produce IFN-g [21] . In the present study, we used the superantigen SEB to stimulate intrahepatic lymphocytes, and we found that the ability of intrahepatic CD4 + and CD8 + T cells to produce IFN-g was significantl lower than that in the periphery in patients with chronic hepatitis C. Our finding are in agreement with those of a recent publication that showed that intrahepatic CD8 + T cells were less responsive than peripheral CD8 + T cells in terms of the anti-CD3-induced production of IFN-g [22] . The reduced IFN-g production by intrahepatic T cells is consistent with the generally tolerant nature of liver [23] , and this may play a role in the persistence of HCV infection. Although SEB stimulates T cells through direct binding to T cell receptors, which resembles the stimulation of T cells by their cognate antigens [24] , the function of HCV-specifi intrahepatic T cells will need to be directly examined in future studies for their exact role in the immunopathogenesis of chronic hepatitis C.
Effector T cells may selectively destroy virus-infected cells via different mechanisms. The cytolytic activity mediated by the granule effector molecules perforin, granzyme A, and granzyme B and the apoptosis mediated by cell-surface FasL that interacts with Fas receptors on target cells are 2 major pathways for T cell-induced cell death [25] [26] [27] . Studies in mouse models have suggested that the perforin system plays an important role in the clearance of viral infections, especially noncytopathic viruses [28] [29] [30] [31] . Hepatocytes, however, have been shown to be inherently resistant to perforin-dependent cytotoxicity mechanisms, whereas FasL/Fas-dependent, cell-mediated cytotoxicity served as the major pathway for the cytotoxic T lymphocyte (CTL)-mediated elimination of virus-infected hepatocytes [31] . In chronic hepatitis C, Fas expression is up-regulated in hepatocytes, especially those in the vicinity of liver-infiltratin lymphocytes [32] . It has been suggested that the Fas/FasL system is involved in the elimination of both HCV antigen-bearing target cells and non-antigen-bearing bystander cells [33] . A study that addressed the balance of FasL/Fas-and perforindependent pathways in the liver by measuring hepatic FasL and perforin mRNA levels showed that the ratio of FasL mRNA to perforin mRNA correlated with serum ALT levels, which suggests that FasL/Fas pathway may be dominant in liver inflam mation [34] . Our data have demonstrated that, in chronic hepatitis C, the average percentage of perforin + CD8 + T cells was lower in the liver than in peripheral blood. Conversely, the percentage of both CD4 + and CD8 + T cells expressing FasL was higher in the liver than in the peripheral blood. These results suggest that the FasL/Fas pathway plays a more important role in the apoptotic activity of intrahepatic than peripheral T cells, and this pathway is likely to be directly involved in the immunopathogenesis of chronic hepatitis C in the liver. Alternatively, the lower content of perforin in intrahepatic CD8 + T cells could reflec the chronic degranulation of intrahepatic HCVspecifi CD8 + T cells chronically exposed to the viral antigens in the absence of critical regulatory signals [35] -another mechanism that renders such cells tolerant to HCV antigens. However, the lower perforin content of the intrahepatic CD8 + T cells is not consistent with the notion that terminally differentiated effector CTLs are preferentially enriched in the liver [36] , which suggests that perforin expression in intrahepatic CD8 + T cells is subjected to unique regulation in the liver.
Our results have demonstrated that a significantl greater portion of intrahepatic than peripheral T cells expressed Fas receptor, which suggests that intrahepatic T cells are more susceptible to FasL-induced apoptosis. It has been reported that mouse liver selectively sequestered activated T cells, which became apoptotic in the liver [37] . A previous study of the HCVinfected human liver also showed a higher rate of apoptosis in IHLs [38] . Of interest, the core protein of HCV has been suggested to promote the Fas-induced apoptosis of T cells [39] . Taken together, these results are in agreement with the notion that the liver is enriched with T cells at the terminal stage of their life cycle, and it therefore may serve as the "graveyard" of T cells [36] .
In patients with chronic infection, but not in those who have cleared the virus, HCV-specifi CD8 + T cells have been found to be defective in their proliferation capability in vitro, which suggests that this functional defect is associated with the persistence of HCV [40] . To assess the proliferation capability of intrahepatic T cells, we performed an in vitro proliferation assay using anti-CD3 and rIL-2-reagents widely used to generate T cell lines and clones. We have demonstrated that both CD4 + and CD8 + T cells isolated from HCV-infected livers did not proliferate under the same conditions that induced vigorous expansion into peripheral T cells. This defect in the proliferation capability of T cells in HCV-infected livers, together with previous finding that such cells frequently undergo apoptosis, suggests that the intrahepatic T cell population is not maintained by local clonal expansion and has to be replenished by the continuous migration of peripheral lymphocytes into the liver. This is likely to be mediated by multiple chemokine receptors expressed on the lymphocyte subsets, as we reported previously [4, 41] . Given the important role that intrahepatic T cells play in the immunopathogenesis of chronic hepatitis C, blocking the migration of T cells into the liver by targeting the chemokine receptors or their chemokine ligands may provide a potential therapy for chronic hepatitis C, assuming that this strategy does enhance HCV replication in the liver.
Of note, the results of our in vitro proliferation experiment did not rule out the possibility that, with prolonged stimulation, a subset of IHLs with proliferation capability can be detected. However, prolonged stimulation also increases the possibility of expanding the number of contaminating PBMCs in the IHL preparation. Hence, proper caution is warranted in interpreting the results of T cell lines and clones generated from liver tissues.
In summary, our results demonstrate the distinct phenotypic and functional characteristics of T cells in the HCV-infected liver. Further characterization of these immune cells, especially those specifi for HCV antigens, may hold the key to understanding the immunopathogenesis and mechanism of the persistence of HCV infection.
